Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-39,060
Closed -$635K – 1518
2021
Q4
$635K Sell
39,060
-175
-0.4% -$2.56K 0.02% 741
2021
Q3
$596K Buy
39,235
+18,200
+87% +$284K 0.02% 739
2021
Q2
$363K Sell
21,035
-800
-4% -$14.7K 0.01% 983
2021
Q1
$426K Sell
21,835
-211
-1% -$4.33K 0.01% 830
2020
Q4
$441K Buy
22,046
+6,496
+42% +$133K 0.02% 751
2020
Q3
$279K Buy
15,550
+3,510
+29% +$86K 0.01% 826
2020
Q2
$325K Buy
12,040
+900
+8% +$24.8K 0.01% 747
2020
Q1
$275K Buy
+11,140
New +$406K 0.02% 681

Sigma Planning's ZGNX Position: Q1 2022 in Review

Sigma Planning sold out of Zogenix (ZGNX) in Q1 2022, closing a stake of 39,060 shares — an estimated $635K sold.

Sigma Planning first reported a position in ZGNX in Q1 2020 and held it in 8 quarters. The position peaked at $635K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Sigma Planning reported no remaining Zogenix position as of Q1 2022 after selling out during the quarter.
  • Sigma Planning sold 39,060 Zogenix shares in Q1 2022, an estimated $635K.
  • Sigma Planning first reported a position in Zogenix in Q1 2020 and held it in 8 quarters.
  • Sigma Planning's Zogenix position peaked at $635K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zogenix as of Q1 2022.

Based on Sigma Planning's 13F filing for Q1 2022, filed 20 Apr 2022.